Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:


Evolutionary gambit to defeat drug resistance in cancer

A therapeutic strategy harnesses evolutionary dynamics to overcome tumor resistance to targeted therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The dual gene drive strategy.


  1. Leighow, S. M. et al. Nat. Biotechnol. (2024).

  2. França, G. S. et al. Preprint at bioRxiv (2022).

  3. Vander Velde, R. et al. Nat. Commun. 11, 2393 (2020).

    Article  Google Scholar 

  4. Duarte, S., Carle, G., Faneca, H., de Lima, M. C. & Pierrefite-Carle, V. Cancer Lett. 324, 160–170 (2012).

    Article  CAS  PubMed  Google Scholar 

  5. Maley, C. C., Reid, B. J. & Forrest, S. Cancer Epidemiol. Biomarkers Prev. 13, 1375–1384 (2004).

    Article  PubMed  Google Scholar 

  6. Gatenby, R. A. & Brown, J. S. Nat. Rev. Clin. Oncol. 17, 675–686 (2020).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Andriy Marusyk.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marusyk, A. Evolutionary gambit to defeat drug resistance in cancer. Nat Biotechnol (2024).

Download citation

  • Published:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing